Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Single vs Planned Double-Debridement Antibiotics and Implant Retention Followed by Chronic Antibiotic Suppression for the Treatment of Acute Periprosthetic Joint Infection: A Prospective, Multicenter, Randomized Clinical Trial

NCT05640336 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT05640336
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05640336 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Single vs Planned Double-Debridement Antibiotics and Implant Retention Followed by Chronic Antibiotic Suppression for the Treatment of Acute Periprosthetic Joint Infection: A Prospective, Multicenter, Randomized Clinical Trial
Lead sponsor
Mayo Clinic
Phase
Not applicable
Overall status
Enrolling by invitation
Start date
March 3, 2023
Completion date
March 31, 2032
Enrollment
490 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

periprosthetic joint infection